Show simple item record

dc.contributor.authorRichmond, Janice P
dc.contributor.authorKelly, Mary Grace
dc.contributor.authorJohnston, Alison
dc.contributor.authorMurphy, Patrick J
dc.contributor.authorO'Connor, Laura
dc.contributor.authorGillespie, Paddy
dc.contributor.authorHobbins, Anna
dc.contributor.authorAlvarez-Iglesias, Alberto
dc.contributor.authorMurphy, Andrew W
dc.date.accessioned2024-03-15T10:05:55Z
dc.date.available2024-03-15T10:05:55Z
dc.date.issued2024-02-29
dc.identifier.issn2055-5784
dc.identifier.pmid38424625
dc.identifier.doi10.1186/s40814-024-01461-z
dc.identifier.urihttp://hdl.handle.net/10147/641208
dc.descriptionOral anti‑cancer medications (OAMs) are being used increasingly within cancer care. OAMs offer the potential to improve patient convenience and increase hospital capacity. The clinical assessment for each cycle of OAMs requires specialist patient review often performed in hospital‑based oncology units. Consequently, any potential improvement in patient expediency or increased hospital capacity that OAMs can offer is not realised. This study aimed to develop and pilot the specialist assessment of patients receiving OAMs by an Advanced Nurse Practitioner (ANP) in a community‑based location. The primary aim of this pilot study was to assess the feasibility of a community‑based ANP‑led integrated oncol‑ ogy care model for adults receiving OAMs in Ireland who met the pre‑specified eligibility criteria. The objectives were to determine the feasibility of a definitive trial of this intervention by measuring patient safety, acceptability to patients and staff and cost of the new model of care. This single‑centre pilot study provided patient care (n = 37) to those receiving OAM therapies within a community setting for a 4‑month period. Consent rate was high with no attrition other than for clinical reasons. There were 151 contacts with the sample during that time. Results demonstrated that the ANP‑led intervention and new model for OAM care was safe, highly acceptable to patients and staff and that related healthcare costs could be captured. Based on the success of this pilot study, the authors conclude that a community‑based ANP‑led integrated oncology care model for adults receiving OAMs is feasible, and a definitive trial is warranted.en_US
dc.language.isoenen_US
dc.rights© 2024. The Author(s).
dc.subjectAdvanced nurse practitioneren_US
dc.subjectCANCERen_US
dc.subjectCancer careen_US
dc.subjectCancer managementen_US
dc.subjectfeasibility studyen_US
dc.subjectoral anticancer medicationsen_US
dc.subjectPrimary careen_US
dc.titleA community-based advanced nurse practitioner-led integrated oncology care model for adults receiving oral anticancer medication: a pilot study.en_US
dc.typeArticleen_US
dc.identifier.journalPilot and feasibility studiesen_US
dc.source.journaltitlePilot and feasibility studies
dc.source.volume10
dc.source.issue1
dc.source.beginpage46
dc.source.endpage
refterms.dateFOA2024-03-15T10:05:56Z
dc.source.countryEngland


Files in this item

Thumbnail
Name:
richmond 2024 a community based ...
Size:
1.347Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record